MYSE Supplements Improve Thyroid Health and Ease Migraines

May 28
1 min read

Research Summary

A study published in the journal Nutrients explored the effects of myoinositol and selenium (MYSE) supplementation on individuals with both migraine and Hashimoto's thyroiditis (HT). Over six months, 163 participants experienced significant improvements in thyroid function and migraine symptoms. Specifically, thyrotropin (TSH) levels decreased, while monthly migraine days (MMDs) and monthly symptomatic drug use (MSDs) also saw reductions, dropping from 14 to 11 days. Free thyroxine (fT4) levels increased slightly, and free triiodothyronine (fT3) remained stable. The reduction in TSH levels was closely linked to decreased migraine frequency, suggesting a possible endocrine-metabolic role in migraine severity. These findings advocate for further research and underscore the importance of addressing thyroid function in affected individuals.

Study Details

📄 Title: Myoinositol and Selenium (MYSE) Supplementation Is Associated with Favorable Changes in Thyroid Parameters and Migraine Outcomes in Patients with Migraine and Hashimoto's Thyroiditis: A Retrospective Cohort Study.

👥 Research Team: Di Lorenzo C et al.

📚 Published In: Nutrients

📅 Publication Date: 2026 May 14

⚕️ Medical Disclaimer: This summary is generated automatically from recent migraine research. Always consult with healthcare professionals for medical advice.